Arrowhead Pharmaceuticals, Inc. company logo
Arrowhead Pharmaceuticals, Inc. logo

ARWR EBITDA

Annual EBITDA

$122.27M$704.76M+120.99%

Summary

Current Value
As of today, ARWR annual EBITDA is $122.27M, up +120.99% on
Historical Performance
ARWR annual EBITDA is up +172.74% over the past 3 years, and up +240.20% over the past 5 years
All-Time High Comparison
ARWR annual EBITDA is currently at its all-time high
3-Year Low Comparison
ARWR annual EBITDA is +120.99% above its 3-year low of -$582.49M reached on
Sector Comparison
ARWR annual EBITDA is higher than 86.84% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

ARWR Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$122.27M+121.0%+172.7%+240.2%+1600.8%
Quarterly EBITDA$50.49M+132.1%+162.2%+204.4%+2324.9%
TTM EBITDA$122.27M+121.0%+172.7%+240.2%+1540.8%
Price$65.93+248.7%+79.1%-18.6%+601.4%
PE Ratio-
Annual Revenue$829.45M+10000.0%+241.0%+842.6%+10000.0%
Annual EPS-$0.01+99.8%+99.3%+98.5%+98.8%
Annual EBIT$98.35M+116.4%+155.1%+205.6%+1217.3%
Annual Net Income$30.11M+104.9%+117.1%+135.6%+507.8%

EBITDA Highs

ARWR Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$122.27Mat high
5Y$122.27Mat high
All$122.27Mat high

EBITDA Lows

ARWR Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$582.49M+121.0%
5Y-$582.49M+121.0%
All-$582.49M+121.0%

EBITDA History

YearValueChange
$122.27M+121.0%
-$582.49M-202.6%
-$192.51M-14.5%
-$168.09M-19.4%
-$140.77M-61.4%
-$87.22M-232.9%
$65.63M+228.1%
-$51.24M-58.6%
-$32.31M+60.7%
-$82.29M-0.8%
-$81.60M-72.5%
-$47.30M-135.2%
-$20.11M-4.0%
-$19.34M-102.3%
-$9.56M-17.4%
YearValueChange
-$8.15M+50.4%
-$16.44M+46.3%
-$30.59M-11.9%
-$27.35M-39.6%
-$19.60M-124.8%
-$8.72M-223.6%
-$2.69M-2,754.0%
-$94.40K+28.8%
-$132.50K-29.0%
-$102.70K-1.1%
-$101.60K-111.2%
-$48.10K-100.4%
-$24.00K+56.2%
-$54.80K-

FAQ

  • What is the current annual EBITDA of ARWR?

    As of today, ARWR annual EBITDA is $122.27M

  • What is 1-year change in ARWR annual EBITDA?

    ARWR annual EBITDA is up +120.99% year-over-year

  • What is 3-year change in ARWR annual EBITDA?

    ARWR annual EBITDA is up +172.74% over the past 3 years

  • How far is ARWR annual EBITDA from its all-time high?

    ARWR annual EBITDA is currently at its all-time high

  • How does ARWR annual EBITDA rank versus sector peers?

    ARWR annual EBITDA is higher than 86.84% of companies in Healthcare sector

  • When is ARWR next annual earnings release?

    As of today, the next annual earnings release for ARWR has not been scheduled

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. ARWR Official Website arrowheadpharma.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
  3. ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
  4. ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr